Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > Some Short pressure

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Dec 15, 2020 11:01am

132 Views

Post# 32108623

RE:RE:RE:RE:Some Short pressure

Half the available float has changed hands in the past week. I'm not terrbily concerned with a little profit taking and short interest.

I think pulling the shoot on everything is a bit premature at this point. Consider that all this movement is based on Mushroom hype and this company does have the ability to post news that a phase 1 trial in a delivery system could begin.

RB928, should THAT trial start .....$4.....

I do imaging this is the focus at this time and a public offering to facilitate that trial would be welcome and send this sckyrocketing

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 7, 2024